MAPK1 and neoplasm: Evidence from oncology studies suggests that activation of the MAPK/Erk signaling pathway could elevate the expression of MMP-2 and MMP-9 in different tumor cells, thereby enhancing their proliferation and invasion and metastasis [40, 41].